Monalizumab-cetuximab combo shows promise in advanced head and neck SCCNovember 19, 2018Immuno-oncologyHead & Neck/Thyroid Cancers
Adding pembrolizumab to cisplatin-based CRT shows promise in HPV+ head and neck cancersNovember 12, 2018Head & Neck/Thyroid CancersImmuno-oncology
Pembrolizumab extends survival of head and neck cancerNovember 1, 2018Head & Neck/Thyroid CancersImmuno-oncology
Worse OS, control of low-risk oropharyngeal cancer with cetuximabOctober 30, 2018Head & Neck/Thyroid Cancers
ESMO 2018: First look at immunotherapy as first-line treatment for HNSCCOctober 12, 2018Head & Neck/Thyroid Cancers
Epacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
First combo trial of mTOR/BRAF inhibition shows potentialSeptember 23, 2018MelanomaLung CancerCNS/Brain CancerGastroenterologyHead & Neck/Thyroid CancersGastrointestinal Cancer
HPV positivity associated with good esophageal adenocarcinoma outcomesAugust 3, 2018Head & Neck/Thyroid CancersGastroenterologyGastrointestinal Cancer
Head and neck cancers: Women less commonly receive intensive chemoJune 2, 2018Head & Neck/Thyroid Cancers
New remote monitoring system lessens symptoms in head and neck cancerMay 22, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancerMay 8, 2018Head & Neck/Thyroid Cancers
Probe linked to smartphone found effective in diagnosing oral cancerApril 25, 2018Head & Neck/Thyroid Cancers
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respectMarch 18, 2018Head & Neck/Thyroid Cancers
Pembrolizumab plus SBRT shows promise for advanced solid tumorsJanuary 27, 2018Immuno-oncologyBreast CancerLung CancerGenitourinary CancerGastroenterologyHead & Neck/Thyroid CancersGynecologic Cancer
